Shares of the drugmaker owned by ValueAct and dumped by Pershing Square closed at less than nine bucks apiece on Tuesday.
Abbott Laboratories and Time Warner saw a surge of hedge fund interest in the final three months of 2016.
The hedge fund headed by David Einhorn posted big gains in its long book but was hurt by its short positions.
An Accenture study finds a large and growing number of investors that want digital advice. Financial service firms better watch out.
Federal Reserve refrains from rate hike; Cooperman to fight insider-trading charges; Mylan CEO testifies before Congress; Yahoo! to admit hack; Apple turns to cars.
Markets react to a lower chance of Fed action this month; Apple to debut new products in major event; U.S. Department of Education shuts down ITT Tech.
As the iPhone maker struggles to come up with the next great thing, labor — not innovation — might turn out to be CEO Tim Cook’s biggest problem.